These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27573737)

  • 1. Macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins are modulated by complement protein C1q.
    Ho MM; Manughian-Peter A; Spivia WR; Taylor A; Fraser DA
    Atherosclerosis; 2016 Oct; 253():38-46. PubMed ID: 27573737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.
    Fraser DA; Tenner AJ
    J Immunol; 2010 Oct; 185(7):3932-9. PubMed ID: 20833838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins.
    Spivia W; Magno PS; Le P; Fraser DA
    Inflamm Res; 2014 Oct; 63(10):885-93. PubMed ID: 25091012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis.
    Pulanco MC; Cosman J; Ho MM; Huynh J; Fing K; Turcu J; Fraser DA
    J Immunol; 2017 Jan; 198(1):472-480. PubMed ID: 27895181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4.
    Park SJ; Lee KP; Kang S; Lee J; Sato K; Chung HY; Okajima F; Im DS
    Cell Signal; 2014 Oct; 26(10):2249-58. PubMed ID: 25035231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome data and gene ontology analysis in human macrophages ingesting modified lipoproteins in the presence or absence of complement protein C1q.
    Ho MM; Fraser DA
    Data Brief; 2016 Dec; 9():362-367. PubMed ID: 27699187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
    Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q/TNF-related protein 1 links macrophage lipid metabolism to inflammation and atherosclerosis.
    Wang XQ; Liu ZH; Xue L; Lu L; Gao J; Shen Y; Yang K; Chen QJ; Zhang RY; Shen WF
    Atherosclerosis; 2016 Jul; 250():38-45. PubMed ID: 27175610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuoXueTongFu Formula Alleviates Intraperitoneal Adhesion by Regulating Macrophage Polarization and the SOCS/JAK2/STAT/PPAR-
    Zhao M; Bian YY; Yang LL; Chen YQ; Wang YJ; Ma YT; Pei YQ; Li WL; Zeng L
    Mediators Inflamm; 2019; 2019():1769374. PubMed ID: 31772499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
    Namgaladze D; Kemmerer M; von Knethen A; Brüne B
    Cardiovasc Res; 2013 Jun; 98(3):479-87. PubMed ID: 23531513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway.
    Espericueta V; Manughian-Peter AO; Bally I; Thielens NM; Fraser DA
    Mol Immunol; 2020 Jan; 117():65-72. PubMed ID: 31739194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
    Nagy ZS; Czimmerer Z; Szanto A; Nagy L
    Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
    Donat C; Thanei S; Trendelenburg M
    Front Immunol; 2019; 10():2712. PubMed ID: 31824501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors.
    Namgaladze D; Morbitzer D; von Knethen A; Brüne B
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):313-20. PubMed ID: 19948841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
    Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways.
    Zhou D; Huang C; Lin Z; Zhan S; Kong L; Fang C; Li J
    Cell Signal; 2014 Feb; 26(2):192-7. PubMed ID: 24219909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.